HBM1020
HBM1020 is a fully human monoclonal antibody targeting B7H7. HBM1020 binds to B7H7 and enhances the anti-tumor response of T cells. HBM1020 can be used in research related to advanced solid tumors.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Human
|
B7H7 |
HBM1020 is a fully human monoclonal antibody targeting B7H7, an immune checkpoint molecule. Due to its high expression in solid tumors and association with poor prognosis, B7H7 emerges as a highly promising target for tumor therapy[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Q9UM44
HHLA2
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)